Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Anticancer drug R&D landscape in China

Fig. 2

Phase 1 study sites and strategies in combination trials. a Three hundred sixty-four phase 1 studies were took on by 83 phase 1 study sites. b Geographic distribution of phase 1 study sites. c Combination strategies in phase 1 trials

Back to article page